Exozymes Inc.
Nasdaq · Healthcare · Biological Products, (No Diagnostic Substances) · Monrovia, CA
EXOZ chart
What traders are saying about $EXOZ
Latest postsExozymes Inc. news
- Form 4 eXoZymes Inc: Damien Alan Perriman (Chief Commercial Officer) For: 9 October
Investing.com Nigeria ·
- Exozymes CCO Damien Perriman sells $19,426 in stock By Investing.com
Investing.com Nigeria ·
- After converting stock awards into 3,922 shares, Exozymes (EXOZ) executive sells 3,729 to cover taxes.
Stock Titan ·
- Exozymes' CCO Damien Perriman Sells 3,729 Shares Following RSU Vesting
Kalkine Media ·
- eXoZymes CEO to Discuss Commercialization, Key Milestones, and Potential Catalysts in Fireside Chat with Water Tower Research
Yahoo Finance ·
- Form 4 eXoZymes Inc: Tyler Paz Korman (Chief Scientific Officer) For: 19 August
Investing.com Nigeria ·
- eXoZymes Selects Curia as Commercial-Scale Manufacturing Partner for NCT
Yahoo Finance ·
- EXoZymes Inc (EXOZ) (Q2 2026) Earnings Call Highlights: Strategic Pivot and 10x Productivity ...
Yahoo Finance ·
- eXoZymes Q2 Earnings Call Highlights
marketbeat.com ·
- eXoZymes Reports Second Quarter 2026 Results and Provides Business Update at 5PM ET Today
Yahoo Finance ·
- eXoZymes' NCT Process Achieves 10-fold Productivity Increase, Advancing Beyond Original Commercial-scale Economic Targets
Yahoo Finance ·
- MDB Capital Holdings LLC (MDBH) (Q2 2026) Earnings Call Highlights: Strategic Pivots and Asset ...
Yahoo Finance ·
Exozymes Inc. key financials
| USD | 2025 | 2024 | 2023 |
|---|---|---|---|
| Revenue | – | – | $70,069 |
| Net income | -$9.2M | -$5.9M | -$2.0M |
| Diluted EPS | $-1.09 | $-0.89 | $-0.33 |
| Total assets (year end) | $6.0M | $13.0M | $3.6M |
| Cash and equivalents (year end) | $3.0M | $9.7M | $66,533 |
Calendar-year figures as reported to the SEC in XBRL filings.
Recent SEC filings
About Exozymes Inc.
- Ticker
- EXOZ (Nasdaq)
- Industry
- Biological Products, (No Diagnostic Substances)
- Headquarters
- Monrovia, CA
- Incorporated in
- NV
- Fiscal year end
- December 31
- SEC CIK
- 2010788
- Former names
- Invizyne Technologies Inc
Frequently asked questions
What exchange is Exozymes Inc. listed on?
Exozymes Inc. trades on the Nasdaq under the ticker symbol EXOZ.
What industry is Exozymes Inc. in?
Exozymes Inc. is classified by the SEC under "Biological Products, (No Diagnostic Substances)", part of the Healthcare sector on StockTweeting.
Where is Exozymes Inc. headquartered?
Exozymes Inc.'s business address on file with the SEC is in Monrovia, CA.
When does Exozymes Inc.'s fiscal year end?
Exozymes Inc.'s fiscal year ends on December 31.
How much revenue did Exozymes Inc. report?
Exozymes Inc. reported $70,069 in revenue for calendar year 2023, according to its SEC filings.